Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 1250.00 | 830.55 | 1613.00 | 1955.00 | 0.8251 | 0.7116 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 1250.00 | 830.55 | 1044.00 | 1955.00 | 0.5340 | 0.2035 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 1250.00 | 830.55 | 1072.00 | 1955.00 | 0.5483 | 0.2295 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 1250.00 | 830.55 | 2000.00 | 1955.00 | 1.0230 | 1.0372 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 1250.00 | 830.55 | 2216.00 | 1955.00 | 1.1335 | 1.2136 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 1250.00 | 830.55 | 1877.00 | 1955.00 | 0.9601 | 0.9351 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 1250.00 | 830.55 | 1208.00 | 1955.00 | 0.6179 | 0.3544 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 1250.00 | 830.55 | 1464.00 | 1955.00 | 0.7489 | 0.5824 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 1250.00 | 830.55 | 1956.00 | 1955.00 | 1.0005 | 1.0008 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 1250.00 | 830.55 | 811.00 | 1955.00 | 0.4148 | -0.0191 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 1250.00 | 830.55 | 2194.00 | 1955.00 | 1.1223 | 1.1958 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 1250.00 | 830.55 | 1770.00 | 1955.00 | 0.9054 | 0.8453 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 1250.00 | 830.55 | 2034.00 | 1955.00 | 1.0404 | 1.0652 |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 1250.00 | 830.55 | 848.00 | 1955.00 | 0.4338 | 0.0170 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1839.00 | 1955.00 | 0.9407 | 0.9034 | |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3678.00 | 3928.50 | 0.9362 | 0.8814 | |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 2500.00 | 1861.36 | 3913.00 | 3928.50 | 0.9961 | 0.9927 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 2500.00 | 1861.36 | 1717.00 | 3928.50 | 0.4371 | -0.0722 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 2500.00 | 1861.36 | 3057.00 | 3928.50 | 0.7782 | 0.5847 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 2500.00 | 1861.36 | 3785.00 | 3928.50 | 0.9635 | 0.9321 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 2500.00 | 1861.36 | 2192.00 | 3928.50 | 0.5580 | 0.1638 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 2500.00 | 1861.36 | 3755.00 | 3928.50 | 0.9558 | 0.9179 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 2500.00 | 1861.36 | 3526.00 | 3928.50 | 0.8975 | 0.8091 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3929.00 | 3928.50 | 1.0001 | 1.0002 | |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 2500.00 | 1861.36 | 3534.00 | 3928.50 | 0.8996 | 0.8129 |